KNC Laboratories Co., Ltd.
Tokyo Stock Exchange 6568.T
KNC Laboratories Co., Ltd. EBT Margin for the year ending March 31, 2024: 22.86%
KNC Laboratories Co., Ltd. EBT Margin is 22.86% for the year ending March 31, 2024, a -9.19% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
-
KNC Laboratories Co., Ltd. EBT Margin for the year ending March 31, 2023 was 25.18%, a 104.35% change year over year.
-
KNC Laboratories Co., Ltd. EBT Margin for the year ending March 31, 2022 was 12.32%, a 26.77% change year over year.
-
KNC Laboratories Co., Ltd. EBT Margin for the year ending March 31, 2021 was 9.72%, a -12.48% change year over year.
-
KNC Laboratories Co., Ltd. EBT Margin for the year ending March 31, 2020 was 11.11%.
Key data
| Date | EBT Margin | Net Income Margin | EBITDA Margin | EBIT Margin |
|---|
Market news
Loading...
Tokyo Stock Exchange: 6568.T
| CEO | Mr. Takuya Maoka |
| IPO Date | March 15, 2018 |
| Location | Japan |
| Headquarters | 7-1-19 Minatojimaminamimachi |
| Employees | 219 |
| Sector | Health Care |
| Industries | |
Description
KNC Laboratories Co., Ltd. engages in the research, development, and production solutions of organic chemicals in Japan. The company offers products for use in the pharmaceutical, electronic-chemical, agrochemical, energy, and environment fields. It offers support services for drugs and functional chemicals. The company was incorporated in 1985 and is headquartered in Kobe, Japan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email